Lexicon Pharmaceuticals Inc (NAS:LXRX)
$ 0.7734 -0.01075 (-1.37%) Market Cap: 279.58 Mil Enterprise Value: 122.41 Mil PE Ratio: 0 PB Ratio: 1.57 GF Score: 43/100

Lexicon Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 12, 2023 / 08:00PM GMT
Release Date Price: $2.29 (+6.51%)
Unidentified Analyst

Good afternoon, ladies and gentlemen. Welcome again to the 41st Annual JPMorgan Healthcare Conference. My name is Edwin [Zhang]. I'm a part of the JPMorgan health care team in the MS and banking side. Today, our presenting company is Lexicon Pharmaceuticals. Our presenter today is Lonnel Coats, who is the Chief Executive Officer for the company. Please join me and welcome him. And also on the panel, we have Jeffrey Wade, who is the Chief Financial Officer; and Craig Granowitz, who is the Chief Medical Officer.

Lonnel Coats
Lexicon Pharmaceuticals, Inc. - CEO & Director

Edwin, thank you so much for the introduction, and thank you to all of those who have tuned in the presentation about Lexicon's progress. As always, I make these presentations on behalf of the extraordinary men and women at Lexicon that work tirelessly every day to advance our innovations into the hand of patients. Now today, I will be making forward-looking statements. Some of those statements will contain risks. Our risks are outlined in our SEC filings and I encourage you to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot